A new kidney disease test gets a faster path to market

US health regulators just made it easier to get a specific kidney disease test approved. This means patients will likely get access to this diagnostic tool sooner.

For years, new medical tests faced a slow, expensive approval process, even for relatively straightforward diagnostics. This reclassification means that a specific test for kidney disease can now bypass some of those hurdles. It sets a precedent for similar tests to follow a faster, less burdensome path, potentially speeding up patient access to new diagnostic tools.